Estradiol valerate injection had a market value of roughly $16 million in the 12 months ending March 2021, according to IQVIA. Hikma is introducing estradiol valerate injection in dosage strengths of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback